HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader -
7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:11812靶标:N/A
External ID: FATTTLab-Algae-Lipid
Protocol:
Cells were pre-grown to mid-log phase in TAP media. For primary screen, cells were seeded at low density of 500,000 / well in 384-well plate. Compound in DMSO was added to each well at a final concentration of 10 micromolar and cells were allowed to grow for 72 hours. At the end of assay, Nile Red (30 uM f.c.) was added and plates were incubated at 37 C for 60 mins in dark. Fluorescence intensity was measured. Readouts were reported as normalized fold change in the intensity of treated versus control.
Comment:
Reference: 1. Wase, N., Tu, B., Black, P. N. & DiRusso, C. C. Phenotypic screening identifies Brefeldin A/Ascotoxin as an inducer of lipid storage in the algae Chlamydomonas reinhardtii. Algal Research 11, 74-84 (2015).
2. Identification and metabolite profiling of chemical activators of lipid accumulation in green algae #Nishikant Wase, Boqiang Tu, James W Allen, Paul N Black, Concetta C DiRusso #Plant Physiology Jun 2017, pp.00433.2017; DOI: 10.1104/pp.17.00433 #http://www.plantphysiol.org/content/early/2017/06/26/pp.17.00433
Patent: DiRusso, C., & Wase, N. (2016). Compounds for Increasing Lipid Synthesis and Storage. United States#NUtech Ventures (Lincoln, NE, US) http://www.freepatentsonline.com/y2016/0312253.html
For additional Information please contact:
Prof. Concetta C. DiRusso Department of Biochemistry University of Nebraska-Lincoln cdirusso2@unl.edu
Nishikant Wase, PhD Department of Biochemistry University of Nebraska-Lincoln nishikant.wase@gmail.com
HIT_COMPOUND_IN_SCREEN
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader -
7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:24983靶标:Huntingtin
External ID: KUHTS-Muma KU-CaM-Htt INH-01
Protocol:
1; Dispense 45 nl compounds (10 mM stocks) using ECHO 555 to Alpha 384 well assay plates. Dispense 45 nl DMSO to control columns 1 and 2 of 384 well plates. 2; Incubate 5 ul of 6XHis-mHTT (Final, 13 nM) with the compounds for 40 mins at room temperature in buffer containing 10 mM Tris.HCl pH 7.4, 1 mM calcium chloride, 150 mM sodium chloride, 0.1% BSA and 20% glycerol. 3; Dispense 5 ul of 6XGST-CaM (Final 13 nM) in buffer A. 4; Incubation; 1 hour (dark at 25C) 5; Dispense 20 ul of Nickel chelate acceptor beads (Final, 20 ugs/ml) and Glutathione donor beads (Final, 30 ugs/ml). Incubate for 2h, room temperature. 6; Detector: Perkin Elmer Enspire, Alphascreen Module (Excitation 680nm/Emission 570nm).
NOTES (numbers refer to Sequence numbers above) 1. Alphascreen bead incubations were performed in green light, TiterTek setting 400rpm. 2. All incubation and addition steps were followed by mixing and centrifugation at 400g,1 min. 3. The percent inhibition for each compound was calculated as follows: 100- [100 *((Test Compound-Median Low Control) / (Median High Control - Median Low Control))]
Where: Test_Compound is defined as wells containing His mHTT + GST CaM in the presence of test compound
High_Control is defined as wells containing His mHTT + GST CaM and DMSO.
Low_Control is defined as wells containing His mHTT and DMSO.
Comment:
All percent inhibition data reported were normalized to high and low controls on a per-plate basis. The results of primary screening data include compounds contributing to assay signal interference, interference with tags binding to Alpha beads, chelators, process related artifacts etc.. The actives were defined as compounds that inhibited Alphascreen reads to greater than 50%.